Full-Time

Case Manager

Posted on 5/9/2026

Mass General Brigham

Mass General Brigham

1-10 employees

Early-stage life science venture investor

Compensation Overview

$28.20 - $68.49/hr

Cambridge, MA, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Master's Degree Social Work required
  • Master's Degree Related Field of Study preferred
  • Master's Degree Mental Health required
  • Experience in lieu of a degree not accepted
  • Social Worker, Licensed Clinical [LCSW - State License]
  • Social Worker, Licensed Independent Clinical [LICSW - State License]
  • Occupational Therapist [State License]
  • Physical Therapist [State License]
  • Certified Rehabilitation Counselor [CRC]
  • Licensed Mental Health Counselor [State License]
  • Licensed Rehabilitation Counselor [Massachusetts]
  • Respiratory Therapist [Massachusetts]
  • Registered Nurse [RN - Massachusetts]
  • Case management, utilization review, or discharge planning experience 2-3 years preferred
  • Giving full attention to what other people are saying, taking time to understand the points being made, asking questions as appropriate, and not interrupting at inappropriate times.
  • Using logic and reasoning to identify the strengths and weaknesses of alternative solutions, conclusions or approaches to problems.
  • Ability to establish strong rapport and relationships with patients and staff.
  • Proficient in Microsoft Office and industry related software programs.
  • Identifying complex problems and reviewing related information to develop and evaluate options and implement solutions.
  • Ability to maintain client and staff confidentiality.
  • Understanding of diagnostic criteria for dual conditions and the ability to conceptualize modalities and placement criteria within the continuum of care.
  • Knowledge of Healthcare and Managed Care preferred
Responsibilities
  • Complete psychosocial assessments covering psychological, social and environmental concerns, including evaluation of mental status.
  • Review daily referrals and screenings of clients.
  • Audit case file on a regular basis for completeness and accuracy.
  • Assist in discharge planning as required
  • Serves and protects the hospital community by adhering to professional standards, hospital care policies and procedures, federal, state, and local requirements, and Joint Commission on Accreditation of Healthcare Organizations (JCAHO) standards.
  • Initiate a complete assessment, to gather and/or verify relevant baseline data, identify their understanding and expectations of their stay, and identify any potential issues/barriers to arranging post inpatient care.
  • Proactively work with patient, caregiver, and the interdisciplinary team, including community providers of medical services, as appropriate, to develop a realistic and timely plan for post inpatient care.
  • Identify and coordinate appropriate resources post discharge for patients requiring homecare, outpatient, or placement in an alternate level of care.
  • Perform ongoing evaluation for appropriateness for the facility’s level of care by applying knowledge of level of care criteria with active collaboration with patients insurance payer
  • Comply with all applicable State and Federal regulations as well as other credentialing bodies, including but not limited to, Joint Commission and CARF, regarding the case management process.
  • Spaulding serves the acute rehabilitation population: stroke, traumatic orthopedic injury burns, spinal cord injury, brain injury.
  • Performs other duties as assigned
  • Complies with all policies and standards
  • Patient care required: Indirect or direct

Mass General Brigham Ventures funds early-stage life science ideas arising from Mass General Brigham’s research network. It provides first access to deal flow and proprietary rights, backing the formation and growth of new companies and technologies. It uses capital and support to help translate bold innovations into drugs and medical technologies that improve patient outcomes worldwide.

Company Size

1-10

Company Stage

N/A

Total Funding

$1.7B

Headquarters

Cambridge, Massachusetts

Founded

2008

Simplify Jobs

Simplify's Take

What believers are saying

  • 20 exits since inception including eight IPOs and twelve acquisitions demonstrate proven value creation.
  • Strategic focus on digital health and AI positions firm for high-growth healthcare innovation trends.
  • Integrated academic-clinical ecosystem provides technical validation and talent pipeline advantages.

What critics are saying

  • Escalating nurse strikes at Mass General Brigham disrupt operations and damage institutional reputation.
  • Portfolio company failures like Instride erode LP confidence and future fundraising capacity.
  • Competing VCs from non-MGB institutions capture superior deal flow, limiting proprietary advantage.

What makes Mass General Brigham unique

  • Proprietary deal flow from Mass General Brigham's research community and Harvard Medical School faculty.
  • Dedicated AI and Digital Innovation Fund targeting venture-stage healthcare companies since 2020.
  • Active company building support through Amplify program beyond capital provision.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Mass General Brigham who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Hybrid Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Conference Attendance Budget

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

401(k) Company Match

Parental Leave

Adoption Assistance

Childcare Support

Relocation Assistance

Employee Referral Bonus

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Meal Benefits

Commuter Benefits

Legal Services

Employee Discounts

Company Social Events

Company News

PR Newswire
Mar 19th, 2026
MGB Home Care clinicians to picket Mass General over stalled contract talks after year of bargaining

Approximately 450 clinicians at Mass General Brigham Home Care, represented by the Massachusetts Nurses Association, will hold an informational picket on 24 March outside Massachusetts General Hospital. The clinicians are seeking their first union contract after more than 20 bargaining sessions since March 2025. The bargaining unit includes registered nurses, occupational therapists, physical therapists, speech language pathologists, social workers and dieticians who voted to join the MNA in June 2024. They are demanding reasonable caseload limits, clear productivity standards, competitive wages and recruitment protections. MGB reported a $59.2 million operating gain in the year ending September 2025, with CEO Dr Anne Klibanski's compensation rising 40% to $8.4 million in 2024. The picket is scheduled for 15:30 to 17:00 and is not a strike.

CityBiz
Oct 7th, 2025
Affinia Therapeutics Secures $40M Series C

Avidity Partners has participated in a $40 million Series C funding round for Affinia Therapeutics, a company specializing in adeno-associated virus (AAV) gene therapies.

Business Wire
Oct 4th, 2025
Predicta Biosciences Secures $23.4M to Scale its Novel Diagnostic and Analytics Platform for Blood Cancers and Autoimmune Diseases

Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic discovery solutions, today announced it has raised an oversubs...

PR Newswire
May 7th, 2025
Carta Healthcare Secures $18.25M Series B1 Funding

Carta Healthcare has secured $18 million in Series B1 funding to enhance its AI-powered clinical data abstraction and analytics. The investment, led by UPMC Enterprises with participation from several health ventures, will support Carta's growth in the life sciences market. The funding follows Carta's acquisition of Realyze Intelligence and aims to expand its customer base and improve healthcare data management. CEO Brent Dover highlighted the investment's role in scaling operations and product deployment.

Fierce Biotech
Feb 12th, 2025
Sanofi-backed Abcuro raises $200M series C to fund pivotal trial of KLRG1 antibody

Sanofi-backed Abcuro has secured